Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.69 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | TPH1 | P17752 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918401 | 0.98 | SLC7A5 (0.71) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| SCHEMBL358908 | 0.98 | SLC7A5 (0.71) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| SCHEMBL3241485 | 0.98 | SLC7A5 (0.71) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Hydrochloric Acid SCHEMBL29401826 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Bromide SCHEMBL14832338 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Bromide SCHEMBL28349416 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Hydrochloric Acid SCHEMBL3166836 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Hydrochloric Acid SCHEMBL6693119 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| SCHEMBL5963611 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 | |
| Ammonia Solution, Strong SCHEMBL6760516 | 0.96 | SLC7A5 (0.69) | SLC7A5TAAR1SLC6A2HDAC8CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006014297-A1 | COBALT(II) COMPLEXES AS PROTEIN TYROSINE KINASE INHIBITORS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20060003980-A1 | Cobalt(II) complexes as protein tyrosine kinase inhibitors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060003980-A1 | Cobalt(II) complexes as protein tyrosine kinase inhibitors | LCK, TYK2, PTK2B | SLC7A5 2339/4885TAAR1 3295/4885SLC6A2 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.